AR124043A1 - Cápsulas blandas de liberación retardada - Google Patents

Cápsulas blandas de liberación retardada

Info

Publication number
AR124043A1
AR124043A1 ARP210103125A ARP210103125A AR124043A1 AR 124043 A1 AR124043 A1 AR 124043A1 AR P210103125 A ARP210103125 A AR P210103125A AR P210103125 A ARP210103125 A AR P210103125A AR 124043 A1 AR124043 A1 AR 124043A1
Authority
AR
Argentina
Prior art keywords
dependent
coating composition
filler material
delayed
release
Prior art date
Application number
ARP210103125A
Other languages
English (en)
Spanish (es)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR124043A1 publication Critical patent/AR124043A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
ARP210103125A 2020-11-11 2021-11-11 Cápsulas blandas de liberación retardada AR124043A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063112453P 2020-11-11 2020-11-11

Publications (1)

Publication Number Publication Date
AR124043A1 true AR124043A1 (es) 2023-02-08

Family

ID=81601948

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210103125A AR124043A1 (es) 2020-11-11 2021-11-11 Cápsulas blandas de liberación retardada

Country Status (13)

Country Link
US (1) US20230404926A1 (cg-RX-API-DMAC7.html)
EP (1) EP4243772A4 (cg-RX-API-DMAC7.html)
JP (2) JP7830457B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230106642A (cg-RX-API-DMAC7.html)
CN (1) CN116648238A (cg-RX-API-DMAC7.html)
AR (1) AR124043A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021379780A1 (cg-RX-API-DMAC7.html)
CA (1) CA3197522A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023007162A2 (cg-RX-API-DMAC7.html)
IL (1) IL302753A (cg-RX-API-DMAC7.html)
MX (1) MX2023005451A (cg-RX-API-DMAC7.html)
TW (1) TW202233164A (cg-RX-API-DMAC7.html)
WO (1) WO2022104339A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024035910A1 (en) * 2022-08-12 2024-02-15 R.P. Scherer Technologies, Llc Coated enteric softgel capsules
BE1030925B1 (nl) * 2022-09-29 2024-04-29 Oystershell Nv Zachte gummy
US12440517B2 (en) 2022-09-29 2025-10-14 Oystershell Nv Soft gummy
US20260124163A1 (en) * 2022-09-29 2026-05-07 Oystershell Nv Soft gummy
BE1030928B1 (nl) * 2022-09-29 2024-04-29 Oystershell Nv Zachte gummy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944096B2 (ja) * 1979-12-24 1984-10-26 森下仁丹株式会社 親水性物質を充填物とするゼラチンカプセルの製造方法
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
AU2013200828A1 (en) * 2002-12-18 2013-03-07 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2960620C (en) * 2014-10-06 2018-06-19 Fuji Capsule Co., Ltd. Method of manufacturing enteric seamless soft capsule
MY184967A (en) * 2014-10-06 2021-04-30 Fuji Capsule Co Ltd Method of producing enteric soft capsule
WO2017019808A1 (en) * 2015-07-27 2017-02-02 Catacore, Inc Compositions for the treatment of cataracts
SG11201901177VA (en) * 2016-08-17 2019-03-28 Eupraxia Pharmaceuticals Inc Sustained local delivery of drugs including antibiotics
CN114072138A (zh) * 2019-06-03 2022-02-18 R.P.谢勒技术有限公司 延迟释放软凝胶胶囊
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment

Also Published As

Publication number Publication date
MX2023005451A (es) 2023-05-23
EP4243772A1 (en) 2023-09-20
JP2023548711A (ja) 2023-11-20
AU2021379780A1 (en) 2023-07-06
TW202233164A (zh) 2022-09-01
WO2022104339A1 (en) 2022-05-19
CO2023007162A2 (es) 2023-06-20
KR20230106642A (ko) 2023-07-13
IL302753A (en) 2023-07-01
US20230404926A1 (en) 2023-12-21
EP4243772A4 (en) 2024-10-23
CA3197522A1 (en) 2022-05-19
JP7830457B2 (ja) 2026-03-16
JP2026086902A (ja) 2026-05-26
CN116648238A (zh) 2023-08-25

Similar Documents

Publication Publication Date Title
AR124044A1 (es) Cápsulas blandas de liberación retardada
CO2023007162A2 (es) Cápsulas de gelatina blanda de liberación retardada
AR119075A1 (es) Cápsulas blandas de liberación diferida
AR089441A1 (es) Capsulas de gelatina/alginato de liberacion retardada que comprenden acidos grasos omega-3 y metodos y usos de las mismas, metodo de manufactura, composicion farmaceutica
AR115269A1 (es) Cápsulas de gelatina blanda entéricas
ES2539305R2 (es) Recubrimiento comestible para la conservación de trozos de fruta, su proceso de fabricación y de aplicación
PE20061136A1 (es) Sistema de capsulas blandas que no son de gelatina
JP2022535539A5 (cg-RX-API-DMAC7.html)
BR112023020963A2 (pt) Composição, método para encapsular microesferas liofilizadas, sistema e método para o controle da liberação de microesferas encapsuladas
BR112014006596A2 (pt) nanopartícula que encapsula uma pluralidade de nanocarreadores, composição, uso de uma nanopartícula, kit, sistema de entrega, processo para obter uma nanopartícula, e, processo de nanoaspersão para obter as nanopartículas
AR100519A1 (es) Envase tipo cápsula de gelatina blanda y su método de fabricación
BR112014004554A2 (pt) sistemas e processos para encapsulamento de cápsulas
WO2012097429A8 (en) Probiotic soft gel compositions
JP2022554247A5 (cg-RX-API-DMAC7.html)
CO2022007168A2 (es) Cápsulas de gelatina blanda de liberación retardada en ambientes de ph más alto
MX2021009844A (es) Conservacion de particulas de ingredientes farmaceuticos activos revestidas funcionalmente producidas mediante procesos de mezcla sin solvente en suspension acuosa.
BR112022024391A2 (pt) Cápsulas de gelatina mole para liberação retardada
BR112021006619A2 (pt) método de preparação de composição líquida encapsulada
CO2021012391A2 (es) Estabilidad api mejorada en capsulas blandas
AR062374A1 (es) Metodo para prevenir la cristalizacion
AR123805A1 (es) Cápsulas blandas de liberación modificada
CL2019001555A1 (es) Preparación farmacéutica y método para su fabricación.
AR087032A1 (es) Composiciones de capsulas de gelatina y metodos para fabricarlas
CO2021015117A2 (es) Composición de naproxeno en cápsula blanda miniatura
AR117223A1 (es) Aparato y proceso para el encapsulado secundario de inclusiones sólidas utilizando el proceso de matriz rotativa